Literature DB >> 28656686

Estimation of genetic risk function with covariates in the presence of missing genotypes.

Annie J Lee1, Karen Marder2,3, Roy N Alcalay2,3, Helen Mejia-Santana2, Avi Orr-Urtreger4,5, Nir Giladi6,7, Susan Bressman8, Yuanjia Wang1.   

Abstract

In genetic epidemiological studies, family history data are collected on relatives of study participants and used to estimate the age-specific risk of disease for individuals who carry a causal mutation. However, a family member's genotype data may not be collected because of the high cost of in-person interview to obtain blood sample or death of a relative. Previously, efficient nonparametric genotype-specific risk estimation in censored mixture data has been proposed without considering covariates. With multiple predictive risk factors available, risk estimation requires a multivariate model to account for additional covariates that may affect disease risk simultaneously. Therefore, it is important to consider the role of covariates in genotype-specific distribution estimation using family history data. We propose an estimation method that permits more precise risk prediction by controlling for individual characteristics and incorporating interaction effects with missing genotypes in relatives, and thus, gene-gene interactions and gene-environment interactions can be handled within the framework of a single model. We examine performance of the proposed methods by simulations and apply them to estimate the age-specific cumulative risk of Parkinson's disease (PD) in carriers of the LRRK2 G2019S mutation using first-degree relatives who are at genetic risk for PD. The utility of estimated carrier risk is demonstrated through designing a future clinical trial under various assumptions. Such sample size estimation is seen in the Huntington's disease literature using the length of abnormal expansion of a CAG repeat in the HTT gene but is less common in the PD literature.
Copyright © 2017 John Wiley & Sons, Ltd. Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Parkinson's disease; censored data; disease risk estimation; mixture distribution; penetrance function

Mesh:

Substances:

Year:  2017        PMID: 28656686      PMCID: PMC5583003          DOI: 10.1002/sim.7376

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  24 in total

Review 1.  Gene-environment interaction: a central concept in multifactorial diseases.

Authors:  Laurence Tiret
Journal:  Proc Nutr Soc       Date:  2002-11       Impact factor: 6.297

2.  Random-effects models for longitudinal data.

Authors:  N M Laird; J H Ware
Journal:  Biometrics       Date:  1982-12       Impact factor: 2.571

3.  GWAS risk factors in Parkinson's disease: LRRK2 coding variation and genetic interaction with PARK16.

Authors:  Alexandra I Soto-Ortolaza; Michael G Heckman; Catherine Labbé; Daniel J Serie; Andreas Puschmann; Sruti Rayaprolu; Audrey Strongosky; Magdalena Boczarska-Jedynak; Grzegorz Opala; Anna Krygowska-Wajs; Maria Barcikowska; Krzysztof Czyzewski; Timothy Lynch; Ryan J Uitti; Zbigniew K Wszolek; Owen A Ross
Journal:  Am J Neurodegener Dis       Date:  2013-11-29

4.  Estimating time-varying effects for overdispersed recurrent events data with treatment switching.

Authors:  Qingxia Chen; Donglin Zeng; Joseph G Ibrahim; Mouna Akacha; Heinz Schmidli
Journal:  Biometrika       Date:  2013       Impact factor: 2.445

5.  Efficient Estimation of Nonparametric Genetic Risk Function with Censored Data.

Authors:  Yuanjia Wang; Baosheng Liang; Xingwei Tong; Karen Marder; Susan Bressman; Avi Orr-Urtreger; Nir Giladi; Donglin Zeng
Journal:  Biometrika       Date:  2015-09-01       Impact factor: 2.445

Review 6.  Detecting gene-gene interactions that underlie human diseases.

Authors:  Heather J Cordell
Journal:  Nat Rev Genet       Date:  2009-06       Impact factor: 53.242

7.  Identification of Genetic Factors that Modify Clinical Onset of Huntington's Disease.

Authors: 
Journal:  Cell       Date:  2015-07-30       Impact factor: 41.582

8.  Pooled analysis of tobacco use and risk of Parkinson disease.

Authors:  Beate Ritz; Alberto Ascherio; Harvey Checkoway; Karen S Marder; Lorene M Nelson; Walter A Rocca; G Webster Ross; Daniel Strickland; Stephen K Van Den Eeden; Jay Gorell
Journal:  Arch Neurol       Date:  2007-07

9.  Parkinson disease phenotype in Ashkenazi Jews with and without LRRK2 G2019S mutations.

Authors:  Roy N Alcalay; Anat Mirelman; Rachel Saunders-Pullman; Ming-X Tang; Helen Mejia Santana; Deborah Raymond; Ernest Roos; Martha Orbe-Reilly; Tanya Gurevich; Anat Bar Shira; Mali Gana Weisz; Kira Yasinovsky; Maayan Zalis; Avner Thaler; Andres Deik; Matthew James Barrett; Jose Cabassa; Mark Groves; Ann L Hunt; Naomi Lubarr; Marta San Luciano; Joan Miravite; Christina Palmese; Rivka Sachdev; Harini Sarva; Lawrence Severt; Vicki Shanker; Matthew Carrington Swan; Jeannie Soto-Valencia; Brooke Johannes; Robert Ortega; Stanley Fahn; Lucien Cote; Cheryl Waters; Pietro Mazzoni; Blair Ford; Elan Louis; Oren Levy; Llency Rosado; Diana Ruiz; Tsvyatko Dorovski; Michael Pauciulo; William Nichols; Avi Orr-Urtreger; Laurie Ozelius; Lorraine Clark; Nir Giladi; Susan Bressman; Karen S Marder
Journal:  Mov Disord       Date:  2013-10-15       Impact factor: 10.338

10.  Statistical methods for analyzing right-censored length-biased data under cox model.

Authors:  Jing Qin; Yu Shen
Journal:  Biometrics       Date:  2009-06-12       Impact factor: 2.571

View more
  1 in total

1.  Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non-Ashkenazi Jewish ancestry.

Authors:  Annie J Lee; Yuanjia Wang; Roy N Alcalay; Helen Mejia-Santana; Rachel Saunders-Pullman; Susan Bressman; Jean-Christophe Corvol; Alexis Brice; Suzanne Lesage; Graziella Mangone; Eduardo Tolosa; Claustre Pont-Sunyer; Dolores Vilas; Birgitt Schüle; Farah Kausar; Tatiana Foroud; Daniela Berg; Kathrin Brockmann; Stefano Goldwurm; Chiara Siri; Rosanna Asselta; Javier Ruiz-Martinez; Elisabet Mondragón; Connie Marras; Taneera Ghate; Nir Giladi; Anat Mirelman; Karen Marder
Journal:  Mov Disord       Date:  2017-06-22       Impact factor: 10.338

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.